0.1551
price down icon16.70%   -0.0311
after-market After Hours: .16 0.0049 +3.16%
loading

Tevogen Bio Holdings Inc Stock (TVGN) Forecast

The Tevogen Bio Holdings Inc (TVGN) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $47.95, representing a +30,815% increase from the current price of $0.1551. The highest analyst price target is $55.14, and the lowest is $40.76.

Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month TVGN Price Target
Average 47.43 (+30,477% Upside)
loading

Is Tevogen Bio Holdings Inc (TVGN) A Buy Now?

Oscillators
Name Value Action
RSI(14) 21.68 Buy
STOCH(9,6) 20.21 Neutral
STOCHRSI(14) 28.04 Neutral
MACD(12,26) -0.0284 Sell
ADX(14) 14.55 Neutral
William %R -92.53 Buy
CCI(14) -302.93 Sell
Buy: 2 Sell: 2 Neutral: 3
Summary: Neutral
Moving Averages
Period Simple Exponential
MA10
0.2511
Sell
0.2358
Sell
MA20
0.2612
Sell
0.2595
Sell
MA50
0.3091
Sell
0.3155
Sell
MA100
0.4107
Sell
0.432
Sell
MA200
0.7268
Sell
0.6511
Sell
Buy: 0 Sell: 10 Neutral: 0
Summary: Sell
According to our latest analysis, TVGN could be considered a Strong Sell, with 17 technical analysis indicators signaling 2 Buy signals, 12 signaling Sell signals and 3 Neutral signals. This might not be a good time to consider opening new positions on TVGN, as trading bearish markets can be challenging and may result in losses.
  1. RSI (Relative Strength Index): The RSI(14) value of 21.68 indicates that TVGN is oversold. This indicates that TVGN price has experienced a significant decline over a specified lookback period, potentially leading to a rebound.
  2. STOCH (Stochastic Oscillator): The STOCH value of 20.21 indicates that TVGN is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
  3. STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 28.04 indicates that TVGN is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
  4. ADX (Average Directional Index): The ADX value of The ADX value of 14.55 indicates that there is no clear directional movement, and the market may be ranging or moving sideways.
  5. CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -302.93 indicates that TVGN is oversold. This means that the price has moved significantly lower than its average, indicating a potential buying opportunity.

Long-term TVGN price forecast for 2025, 2030, 2035, 2040, 2045 and 2050

Based on our analysis about Tevogen Bio Holdings Inc financial reports and earnings history, Tevogen Bio Holdings Inc (TVGN) stock could reach $167.03 by 2030, $334.65 by 2040 and $343.48 by 2050. See the projected annual prices until 2050 of the Tevogen Bio Holdings Inc stock below:

  • Tevogen Bio Holdings Inc (TVGN) is expected to reach an average price of $340.63 in 2035, with a high prediction of $340.63 and a low estimate of $55.82. This indicates an $219.52K% rise from the last recorded price of $0.1551.
  • Tevogen Bio Holdings Inc (TVGN) stock is projected to chart a bullish course in 2040, with an average price target of $242.39, representing an $156.18K% surge from its current level. The forecast ranges from a conservative $242.72 to a sky-high $334.65.
  • Our analysts predict Tevogen Bio Holdings Inc (TVGN) to jump 342.19K% by 2045, soaring from $530.89 to an average price of $530.89, potentially reaching $656.61. While $530.89 is the low estimate, the potential upside is significant.
  • Tevogen Bio Holdings Inc (TVGN) stock is expected to climb by 2050, reaching an average of $187.80, a $120.98K% jump from its current level. However, a wide range of estimates exists, with high and low targets of $343.48 and $187.94, respectively, highlighting the market's uncertainty.

Tevogen Bio Holdings Inc Stock (TVGN) Year by Year Forecast

Tevogen Bio Holdings Inc Stock (TVGN) Price Forecast for 2026

The predicted value for Tevogen Bio Holdings Inc (TVGN) in 2026 is set at an average of $42.45. Estimates vary from a peak of $75.89 to a trough of $9.0019, indicating an +27,267% surge from the present price of $0.1551.
Month Average Low High Change from today's price
April, 2026 $40.24 $40.76 $55.14 +25,844%
May, 2026 $26.43 $26.66 $35.78 +16,940%
June, 2026 $16.19 $10.42 $21.97 +10,341%
July, 2026 $50.14 $50.55 $67.35 +32,227%
August, 2026 $34.50 $34.84 $44.60 +22,144%
September, 2026 $20.62 $11.84 $29.41 +13,198%
October, 2026 $61.92 $61.92 $75.89 +39,820%
November, 2026 $43.31 $43.70 $55.00 +27,821%
December, 2026 $18.67 $18.81 $36.80 +11,935%

Tevogen Bio Holdings Inc Stock (TVGN) Price Forecast for 2027

For 2027, Stockscan's Analyst expects the average price target for Tevogen Bio Holdings Inc (TVGN) is $61.65, with a high forecast of $110.05 and a low forecast of $13.26. This indicates an +39,651% increase from the last price of $0.1551.
Month Average Low High Change from today's price
January, 2027 $74.12 $13.26 $84.43 +47,688%
February, 2027 $53.41 $53.59 $67.60 +34,333%
March, 2027 $26.66 $26.86 $47.25 +17,088%
April, 2027 $88.57 $14.68 $92.97 +57,006%
May, 2027 $63.44 $63.96 $81.02 +40,805%
June, 2027 $34.90 $35.00 $56.79 +22,399%
July, 2027 $101.51 $16.10 $101.51 +65,348%
August, 2027 $75.54 $75.95 $95.10 +48,601%
September, 2027 $44.48 $44.71 $67.80 +28,578%
October, 2027 $27.40 $17.51 $37.28 +17,564%
November, 2027 $89.50 $89.50 $110.05 +57,607%
December, 2027 $55.29 $55.62 $80.39 +35,547%

Tevogen Bio Holdings Inc Stock (TVGN) Price Forecast for 2028

In 2028, Tevogen Bio Holdings Inc (TVGN) is projected to reach an average price of $81.57, with a high projection of $144.21 and a low estimate of $18.93. This indicates an +52,493% rise from the last price of $0.1551.
Month Average Low High Change from today's price
January, 2028 $26.53 $26.67 $47.46 +17,007%
February, 2028 $103.90 $18.93 $118.59 +66,887%
March, 2028 $66.83 $67.23 $95.19 +42,990%
April, 2028 $36.72 $36.91 $57.59 +23,573%
May, 2028 $111.34 $20.35 $127.13 +71,687%
June, 2028 $79.67 $79.85 $102.09 +51,268%
July, 2028 $47.14 $47.24 $70.78 +30,297%
August, 2028 $128.53 $21.77 $135.67 +82,771%
September, 2028 $92.45 $92.97 $118.25 +59,506%
October, 2028 $58.92 $59.15 $83.06 +37,888%
November, 2028 $144.21 $23.19 $144.21 +92,879%
December, 2028 $107.28 $107.69 $135.06 +69,068%

Tevogen Bio Holdings Inc Stock (TVGN) Price Forecast for 2029

The 2029 price forecast for Tevogen Bio Holdings Inc Stock (TVGN) is $101.49 on average, with a high prediction of $178.37 and a low estimate of $24.61. This represents an +65,335% increase from the previous price of $0.1551.
Month Average Low High Change from today's price
January, 2029 $62.53 $62.76 $96.81 +40,216%
February, 2029 $38.60 $24.61 $52.59 +24,787%
March, 2029 $123.99 $123.99 $152.75 +79,840%
April, 2029 $85.66 $86.05 $112.14 +55,126%
May, 2029 $36.37 $36.51 $74.22 +23,347%
June, 2029 $141.12 $26.03 $161.29 +90,886%
July, 2029 $100.69 $100.87 $129.67 +64,816%
August, 2029 $49.29 $49.49 $89.60 +31,678%
September, 2029 $160.50 $27.45 $169.83 +103.38K%
October, 2029 $105.94 $106.12 $148.02 +68,203%
November, 2029 $62.46 $62.56 $94.31 +40,168%
December, 2029 $178.37 $28.87 $178.37 +114.90K%

Tevogen Bio Holdings Inc Stock (TVGN) Price Forecast for 2030

Tevogen Bio Holdings Inc Stock (TVGN) is expected to reach an average price of $117.14 in 2030, with a high forecast of $203.99 and a low forecast of $30.28. This signifies an +75,424% surge from the last price of $0.1551.
Month Average Low High Change from today's price
January, 2030 $121.45 $121.98 $167.03 +78,207%
February, 2030 $76.97 $77.20 $109.32 +49,526%
March, 2030 $47.56 $30.28 $64.84 +30,565%
April, 2030 $151.57 $151.57 $186.91 +97,626%
May, 2030 $92.71 $93.04 $137.53 +59,673%
June, 2030 $44.23 $44.37 $79.95 +28,419%
July, 2030 $158.47 $31.70 $195.45 +102.07K%
August, 2030 $109.18 $109.58 $143.88 +70,295%
September, 2030 $59.35 $59.54 $95.01 +38,163%
October, 2030 $178.34 $33.12 $203.99 +114.88K%
November, 2030 $126.95 $127.13 $164.16 +81,752%
December, 2030 $74.70 $74.80 $113.13 +48,065%
$45.68
price down icon 3.69%
$53.83
price down icon 6.87%
$29.72
price up icon 0.68%
$101.95
price down icon 1.78%
$143.57
price down icon 4.21%
biotechnology ONC
$292.94
price down icon 2.03%
Cap:     |  Volume (24h):